Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Panacise Bio Inc
Profile last edited on: 10/30/19      CAGE: 82M28      UEI: W3AFTLZB6EL4

Business Identifier: Universal targeting system for immunotherapy
Year Founded
2015
First Award
2018
Latest Award
2018
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1168 Legend Oaks Drive
Chapel Hill, NC 27517
   (919) 391-8968
   N/A
   www.panacisebio.com
Location: Single
Congr. District: 04
County: Orange

Public Profile

Panacise Bio is organized around research related to cell signaling pathways - developing CAR-T applications using molecular evolution techniques associated with targeting ligands and mRNA display technology. The firm is developing self-assembling protein multimers with multi-targeting specificity for diagnostic and therapeutic purposes, such as for cancer surface markers and immune checkpoints.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$224,991
Phase II Dollars
$0
Total Awarded
$224,991

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2018 1 NIH $224,991
Project Title: Innovative Tme-Specific Pro-Car T-Cells for Immunotherapy of Solid Tumors

Key People / Management

  Jingjing Li

  Rihe Liu

Company News

There are no news available.